Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs
Zhuoya Deng,1– 3,* Yuying Tian,1,* Jing Wang,1 Yongru Xu,1 Zherui Liu,3,4 Zhaohui Xiao,1 Zhaohai Wang,1 Minggen Hu,1 Rong Liu,1 Penghui Yang1 1Faculty of Hepato-Pancreato-Biliary Surgery, Institute of Hepatobiliary Surgery, the First Medical Center, Chinese PLA General Hospital, Beij...
Saved in:
| Main Authors: | Deng Z, Tian Y, Wang J, Xu Y, Liu Z, Xiao Z, Wang Z, Hu M, Liu R, Yang P |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-03-01
|
| Series: | International Journal of Nanomedicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/enhanced-antitumor-immunity-through-t-cell-activation-with-optimized-t-peer-reviewed-fulltext-article-IJN |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Narrative Review of the OX40-OX40L Pathway as a Potential Therapeutic Target in Atopic Dermatitis: Focus on Rocatinlimab and Amlitelimab
by: Asaad Abdelhalim, et al.
Published: (2024-11-01) -
OX40–OX40L Axis in Cutaneous T-Cell Lymphomas: Pathogenic, Prognostic, and Potential Therapeutic Perspectives
by: Alba Guglielmo, et al.
Published: (2025-05-01) -
OX40/OX40L as a Therapeutic Target in Atopic Dermatitis: A Scoping Review
by: Valenzuela F, et al.
Published: (2025-05-01) -
Combined TNF-α and OX40L targeting as a new treatment option for hidradenitis suppurativa
by: Thomas Leeuw, PhD, et al.
Published: (2025-08-01) -
FR - OX40: una diana terapéutica prometedora en la dermatitis atópica moderada-grave
by: M. Zulaika-Lloret, et al.
Published: (2025-05-01)